VDR and neuroblastoma: Kaplan–Meier survivalanalyses at the system-selected expression cutoffs (microarray dataand tools available at R2-Genomics Analysis and Visualization Platform https://hgserver1.amc.nl/cgi-bin/r2/main.cgi) showed that VDR mRNA enrichments correlated with increased mortalitiesin lung (p = 0.0043) and pancreatic cancer patients(p = 0.004), neuroblastoma patients (p = 1.7 × 10–5), breast cancer (p = 0.011), glioma (p = 0.0048), cervical cancer(p = 0.055), liver cancer (p = 0.048),ovarian cancer (p = 0.09), and bladder cancer (p = 0.05) patients (Figure S2A–I).